In the latest report from CHOP’s Cancer Center, we highlight some of the ways our clinicians — and philanthropic partners — are breaking new ground in care and treatment for children with pediatric cancers.
- A $14.5 million “Dream Team” grant to fund cancer research at CHOP as clinicians use new technologies and research to create innovative treatments for pediatric cancers
- Emily Whitehead, the first child to receive an experimental immunotherapy of modified T-cells that completely eliminated leukemia in her body, and the hope this therapy offers to other children
- A breakthrough in targeted therapy for rare cancers and how it helped cure a 3-year-old girl with neuroblastoma
- A legacy gift that promotes the well-being of children with cancer by providing emotional and psychosocial support
- Expanding opportunities to raise funds and awareness for the Cancer Canter and Cancer Center families
View on ISSUU
Download the report (PDF)